Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2024-11.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Should Abdominoperineal Excision Be Considered as the Initial Treatment for a Primary Anorectal Malignant Melanoma?
Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Korean Soc Coloproctol > Volume 27(1); 2011 > Article
Editorial
Should Abdominoperineal Excision Be Considered as the Initial Treatment for a Primary Anorectal Malignant Melanoma?
Jae Hwan Oh
Journal of the Korean Society of Coloproctology 2011;27(1):4-4.
DOI: https://doi.org/10.3393/jksc.2011.27.1.4
Published online: February 28, 2011

Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Correspondence to: Jae Hwan Oh, M.D. Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Madu 1-dong, Ilsandong-gu, Goyang 410-769, Korea. Tel: +82-31-920-1637, Fax:+82-31-920-2798, jayoh@ncc.re.kr

© 2011 The Korean Society of Coloproctology

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 2,200 Views
  • 20 Download
See Article on Page [Related article:] 27-30
An anorectal melanoma is a rare tumor with poor survival. The clinical diagnosis of an anorectal melanoma is difficult because of its nonspecific symptoms and the lack of pigmentation in a significant proportion of lesions (37% in this report). To my knowledge, this is the largest clinical series studying anorectal melanomas in Korea even though the number of cases (19 cases) is small.
Although the majority of patients die of systemic metastasis, the role of adjuvant chemotherapy and immunotherapy in the treatment of an anorectal melanoma is minimal. The major debate is the extent of surgery (wide local excision versus radical resection). Within the limitation of a small number of cases and a short follow up, this study suggests that the abdominoperineal resection (APR) may provide a longer survival, compared with the wide local excision, in cases involving an anorectal melanoma.
In a retrospective study at the Memorial Sloan-Kettering Cancer Center, Yeh et al. [1] reported a change in practice patterns during 20 years. In their study of 46 patients with an anorectal melanoma, the authors noted a paradigm shift in the treatment strategy from APR to local excision (LE). They reported that, between 1984 and 1996, 15 of 21 (71%) patients treated for primary an anorectal melanoma underwent an APR. From 1997 to 2003, however, 21 of 25 (84%) patients treated for an anorectal melanoma underwent a LE. During these respective periods, no changes were seen in the thicknesses and the diameters of the tumors. In addition, the pattern of relapse, the time to relapse, and the disease-specific mortality remained similar in these two cohorts. Despite the clear change in practice patterns during these two periods, the outcomes were not significantly different, regardless of the extent of resection. The five-year disease-specific survival for the entire cohort was 34%, with a median follow-up of 39 months for survivors. Thirty-four (74%) of 46 patients relapsed, with a median relapse-free survival of 10 months and an overall recurrence rate of 53% at 1 year. The majority of patients developed distant recurrences. No differences were seen in patterns of relapse between patients treated with an APR or a LE: 5 of 19 (26%) patients in the APR group and 7 of 27 (26%) in the LE group developed local recurrence as the first site of relapse. Survival was similar in both groups, with 5-year disease-specific survivals of 32% for the APR group and 35% for the LE group. These findings suggest that local recurrence and survival in patients with an anorectal melanoma are not associated with the extent of resection.
A systematic review that included 14 series also showed no stage-specific survival advantage for the APR [2]. Recently Nilsson and Ragnarsson-Olding [3] reported that there was no statistically significant difference in terms of median survival (11 months vs. 14 months) or the five-year survival rate (7% vs. 15%) between patients treated with the APR or the LE (P = 0.084). When 72 patients in whom a R0 resection had been achieved were compared with patients having involved margins (R+), there was a significant difference in survival in favor of the R0 resection; thus, both the APR and the LE seemed appropriate for treating an anorectal melanoma, provided clear margins could be achieved. Because of the APR having no survival advantage over the LE and because of the poor prognosis associated with an anorectal melanoma, further consideration must be given to quality-of-life issues when making treatment decisions between these two treatment options.
  • 1. Yeh JJ, Shia J, Hwu WJ, Busam KJ, Paty PB, Guillem JG, et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg 2006;244:1012–1017. ArticlePubMedPMC
  • 2. Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg 2005;189:446–449. ArticlePubMed
  • 3. Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg 2010;97:98–103. ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Should Abdominoperineal Excision Be Considered as the Initial Treatment for a Primary Anorectal Malignant Melanoma?
        J Korean Soc Coloproctol. 2011;27(1):4-4.   Published online February 28, 2011
        Close
      • XML DownloadXML Download
      Should Abdominoperineal Excision Be Considered as the Initial Treatment for a Primary Anorectal Malignant Melanoma?
      Should Abdominoperineal Excision Be Considered as the Initial Treatment for a Primary Anorectal Malignant Melanoma?

      Ann Coloproctol : Annals of Coloproctology Twitter Facebook
      TOP